🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The pharmacokinetics of 50 mg BIBR 1048 administered as two newly developed...
Status
Completed
Location
Multiple Locations
Start Date
2001-04
Trial ID
NCT02170805
Study to investigate the relative bioavailability of BIBR 953 ZW after admi...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT02170597
Treatments Being Tested
Investigation of the relative bioavailability of BIBR 953 ZW after administ...
Status
Completed
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT02170974
Treatments Being Tested
Study to investigate whether and to what extent the suggested P-glycoprotei...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT02173717
Treatments Being Tested
To assess the extent of absorption of 150 mg of BIBR 1048 administered as c...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT02170610
Treatments Being Tested
To assess the amount of BIBR 953 ZW in urine of 50 mg of BIBR 1048 bid over...
Status
Completed
Location
Multiple Locations
Start Date
2001-10
Trial ID
NCT02170896